TAK-928 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,996 results for “TAK-928”

Trials

View all 4601 →

A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer

600 participants · First posted Oct 15, 2025

Safety of AM-928 Infusion in Advanced Solid Tumors

38 participants · First posted Jan 18, 2023

A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)

5 participants · First posted Jan 9, 2018

Drugs

View all 903 →

BQ-928

YM-928

CH-928

Organizations

View all 53 →

YIU TAK PHARMACEUTICAL TRADING LIMITED

Hong Kong, China

Yan Chai Hospital

Hong Kong, China

Aponia Laboratories, Inc.

United States

News

View all 439 →

Takeda to Present Late-Breaking Phase 3 Data for Claudin 18.2 ADC Arcotatug Tavatecan at ESMO 2026

Innovent Advances First-in-Class IBI363 to Pivotal Trials for Immunotherapy-Resistant Lung Cancer

Japanese Dengue Vaccine TAK-003 Approved for Use in Argentina

Page 1 of 600